Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-06 | Amended | $1,312,337 | $359,999 | Equity Only | 06b | SEC link |
| 2024-10-21 | New | $952,338 | $952,338 | Equity Only | 06b | SEC link |
| 2023-09-14 | New | $899,980 | $899,980 | Other | 06b | SEC link |
| 2023-09-14 | New | $1,385,262 | $1,385,262 | Equity Only | 06b | SEC link |
| 2023-09-14 | New | $342,722 | $342,722 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Ephraim Fuchs | Director |
| Robert Tennant | Executive |